precious-metals-investing Element79 Gold Corp Files NI 43-101 Technical Report for Elephant Project in Nevada's Battle Mountain District
precious-metals-investing Element79 Gold Corp Secures Reclamation Bond Approval for Gold Mountain Exploration Project
precious-metals-investing Element79 Gold Corp. to Showcase Nevada Focus and Growth Strategy at Munich Rohstoffmesse 2025
precious-metals-investing Element79 Gold Corp Obtains 2-Year Extension of Drilling Permit for Gold Mountain Project
precious-metals-investing Element79 Gold Corp. Announces Changes to Board of Directors with Eye to Drive Corporate Growth
precious-metals-investing Element79 Gold Corp Engages Rangefront Mining Services to Complete Ni 43-101 Technical Report on Elephant Project
precious-metals-investing Element79 Gold Corp. Announces Filing of NI 43-101 Technical Report for Gold Mountain Project, Nevada
precious-metals-investing Element79 Gold Corp Announces Corporate Update and Strategic Leadership Changes With Focus On Accelerating Nevada Asset Development
precious-metals-investing Element79 Gold Engages Rangefront Mining Services to Prepare NI 43-101 Technical Report on Gold Mountain Project; Site Visit Completed
precious-metals-investing Element79 Gold Corp Announces Execution of Definitive Agreement to Acquire Gold Mountain Project in Nevada
precious-metals-investing Metals & Mining Virtual Investor Conference: Presentations Now Available for Online Viewing
precious-metals-investing Metals & Mining Virtual Investor Conference Agenda Announced for July 23rd and 24th
precious-metals-investing Element79 Gold Corp Welcomes Michael Smith as Vice President, Corporate Development
precious-metals-investing Element79 Gold Corp to Present at the Metals & Mining Virtual Investor Conference July 23
Alrajhi Medicine to Digitize its Healthcare Operations with Oracle to Foster Better Patient and Staff Experiences
Zscaler 2026 AI Threat Report: 91% Year-over-Year Surge in AI Activity Creates Growing Oversight Gap for Global Enterprises
Vizsla Copper Receives Letter of Support from Alaska Governor and Outlines 2026 Exploration Plans at the Palmer Project
Genentech Announces Positive Phase II Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People Living With Obesity
